
Opinion|Videos|April 11, 2025
Determining Appropriate Candidates for JAK Inhibitor Therapy
Panelists discuss how to identify suitable patients for JAK inhibitor therapy by evaluating disease severity, medical history, risk factors, and individual treatment goals while considering contraindications and safety considerations.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
2
Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
3
Pilot Study Tests Oral NAC as Adjunct in Vitiligo Therapy
4
Day 1 Recap: Elevate-Derm Fall Conference
5

















